Courtesy-Mint
Due to the shortage of vaccine doses, several vulnerable hotspots have stalled the COVID-19 vaccination programs around the world with many of those shortages could be tracked back to a single company which is the Serum Institute of India.
Aiming at securing equitable global rollout, the world health organization (WHO) backed an initiative for the same while Serum was the named as the top supplier of COVID-19 shots to Covax last year. But the Indian company got its abilities to satisfy the orders hampered due to a factory fire, ban on exports yet have been dogged by such setbacks.
Out of the minimum order of 200 million doses ordered from Serum, has received only 30 million so far. Covax has pledged to send shots to some 92 countries. Serum’s travail of how the effort to inoculate against COVID-19 has failed the developing world has become a key illustration now along with being an example for becoming over-reliant on one manufacturer amid a global crises.
The emergence of dangerous variants and lengthen the global pandemic could be fueled due to low level of vaccination in poorer nations has been warned by the public health experts and the World Health Organisation (WHO) mentioning about the ‘Shortage’. On imposing a ban on the export of COVID-19 vaccine amid the county’s devastating second wave in the month of April, the company has been unable to send any shots of the COVID-19 vaccine ever since, although some of it’s problems and barriers had commenced long before the Indian Government imposed a ban on the export.